1Lebovitz HE, Dole JE, Patwardhnan R, et al. Rosiglitazone monotherapy is effective in patie nts with type 2 diabetes. J Cin Endocrinol Metab 2001 ,86:280- 288. 被引量：1
2Mohanty P, Aljada A, Ghanim H, et al. Evidence for a potent anti - inflammatory effect of rosiglitazone. J Clin Endocrinol Meatab 2004,89(6) :2728 - 35. 被引量：1
3Steward M, Jones NP, Krieder M, et al. Combiation effects If rosiglitazone and atorvas tatin on the dyslipidemia association with type 2 diabetes. Diabetologia 2001,44 (Suppl 1 ) : Abstract 854. 被引量：1
4Freed M, Fuell D, Menci L, et al. Effects of combination therapy with rosiglitaxzone and glibenclamide on PAI- 1 and tPA in patients with type 2 diabetes. Doabe tologia 2000,43(Suppl 1) :A1024. 被引量：1
5Boden G, Ruiz J, Kim CJ, et al. Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol, 1996,270(2 Pt 1):E251-258. 被引量：1
6Kawai K, Yokota C, Ohashi S, et al. Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia, 1995, 38:274-276. 被引量：1
7Straub SG, James RF, Dunne MJ, et al. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes, 1998,47:758-763. 被引量：1
8Gjessing HJ, Reinhold B, Pedersen O. The effect of chronic hyperglycaemia on the islet B-cell responsiveness in newly diagnosed type 2 diabetes. Diabet Med, 1992,9:601-604. 被引量：1
9Ko GT, Chan JC, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem, 1998,35:62-67. 被引量：1
10Wolffrenbuttel BHR,Gomist R,Squatrito S,et al.Addition of low-dose rosiglitazone to sulfonylurea therapy improves glycaemic control in type 2 diabetic patients.Diabetic Med,2000,17:40-47. 被引量：1
